Ellipsys Vascular Access System Post Market Surveillance (PS) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.
Also called NCT04484220
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 142 participants
- Sponsor
- Registry
-
NCT04484220
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04484220. Allocation not applicable; no masking; primary purpose other. Start 2021-04-13 (actual); primary completion 2025-03-31 (actual). Results posted on 2026-05-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ellipsys Vascular Access System Post Market Surveillance (PS) Study
- Condition
- Renal Disease, End Stage
- Condition
- Kidney Disease, End-Stage
- Condition
- AV Fistula
- Condition
- Fistulas Arteriovenous
- Intervention (Device)
- Ellipsys Vascular Access System
- Lead sponsor
- Medtronic Endovascular
Record details
- Record id
cardio:ct-nct04484220- Content hash
903fcd5b72b21d053da75a32cc3e0511799361e4707c4c8aa315159fbaa6e20f